MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Danaher Corporation DIO Ratio 2011-2026 | DHR
Annual DIO Ratio Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87.6 | 92.9 | 99.2 | 96.6 | 96.5 | 72.9 | 75 | 79.4 | 82.6 | 82.7 | 78 | 70.6 | 71.1 | 74.8 | 82.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 99.2 | 70.6 | 82.8 |
Quarterly DIO Ratio Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99.5 | - | - | - | - | 95.3 | 89.3 | - | - | 44.8 | 88.6 | - | - | - | 39.1 | - | - | - | 39.9 | - | - | - | 40.9 | - | 84.4 | 80 | 84.7 | - | 84.5 | 83.8 | 85.2 | - | 103 | 82.5 | 79.5 | - | 73.1 | 71.3 | 73.6 | - | 72.5 | 72.6 | 77.5 | - | 77.4 | 75.3 | 78.8 | - | 71.8 | 94.6 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 103 | 39.1 | 76.6 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
97.1 | $ 115.35 | -2.33 % | $ 35.1 B |  USA |
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 22.48 | -1.58 % | $ 234 M |  China |
 |
Bioventus
BVS
|
177 | $ 8.45 | -7.14 % | $ 563 M | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 27.23 | -2.44 % | $ 756 M | USA |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 175.23 | -3.37 % | $ 8.69 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Co-Diagnostics
CODX
|
304 | - | - | $ 79.8 M | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 14.59 | 2.41 % | $ 441 M | USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
137 | $ 124.76 | -2.71 % | $ 19.8 B | USA |
 |
BioNano Genomics
BNGO
|
245 | $ 1.11 | -1.36 % | $ 1.41 M | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 199.8 | -2.07 % | $ 22.2 B | USA |
 |
IDEXX Laboratories
IDXX
|
84.3 | $ 607.19 | -1.9 % | $ 48.8 B | USA |
 |
Exact Sciences Corporation
EXAS
|
60.9 | $ 103.5 | 0.17 % | $ 19.5 B | USA |
 |
DarioHealth Corp.
DRIO
|
165 | $ 9.69 | -3.0 % | $ 275 M |  Israel |
 |
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 269.52 | -2.34 % | $ 22.4 B | USA |
 |
DexCom
DXCM
|
115 | $ 68.5 | -3.1 % | $ 26.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B |  Niderland |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 107.08 | -3.19 % | $ 8.83 B |  Irlanda |
 |
Lantheus Holdings
LNTH
|
40.4 | $ 72.86 | -4.53 % | $ 4.92 B | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 17.91 | -4.48 % | $ 954 M | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
Mettler-Toledo International
MTD
|
79 | $ 1 215.85 | -3.66 % | $ 25.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
42.8 | $ 5.15 | 0.29 % | $ 477 M | USA |
 |
NeoGenomics
NEO
|
24.4 | $ 8.92 | -2.3 % | $ 1.14 B | USA |
 |
Guardant Health
GH
|
82.1 | $ 91.56 | -1.1 % | $ 11.5 B | USA |
 |
Natera
NTRA
|
25.8 | $ 196.94 | -0.1 % | $ 19.4 B | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | Israel |
 |
OPKO Health
OPK
|
45.2 | $ 1.18 | 0.43 % | $ 819 M | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |